155 related articles for article (PubMed ID: 6223588)
1. [The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer].
Nakanishi K; Toge T; Hamamoto S; Tanada M; Itagaki E; Kohno H; Yanagawa E; Hattori T
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1827-31. PubMed ID: 6223588
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
[TBL] [Abstract][Full Text] [Related]
3. Induction of suppressor cell activities in normal lymphocytes by sera from gastric cancer patients.
Toge T; Tanada M; Yajima K; Kohno H; Itagaki E; Hattori T
Clin Exp Immunol; 1983 Oct; 54(1):80-6. PubMed ID: 6225584
[TBL] [Abstract][Full Text] [Related]
4. Increased number of suppressor T-cells and impaired IL-2 mediated T-cell function in peripheral blood of gastric cancer patients.
Tsubono M; Nio Y; Shiraishi T; Morimoto H; Tseng CC; Kawabata K; Masai Y; Fukumoto M; Tobe T
J Clin Lab Immunol; 1990 Nov; 33(3):107-15. PubMed ID: 1966999
[TBL] [Abstract][Full Text] [Related]
5. [Immunosuppressive acidic glycoprotein (IAP) and immunosuppressive substance].
Ogoshi K; Kondoh Y; Nakasaki H; Tajima T; Mitomi T
Gan No Rinsho; 1983 Aug; 29(9):987-90. PubMed ID: 6688640
[TBL] [Abstract][Full Text] [Related]
6. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
Itagaki E; Toge T; Tanada M; Hamamoto S; Seto Y; Kohno H; Hattori T
Gan To Kagaku Ryoho; 1984 Jan; 11(1):123-9. PubMed ID: 6230053
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study on serum immunosuppressive factors in gastric cancer patients--with special reference to preoperative IAP values and the influence of surgical stress].
Yokoyama Y; Saji S; Niwa H; Takao H; Kida H; Umemoto T; Kawata R; Sakata K; Tanaka S
Gan No Rinsho; 1985 Aug; 31(10):1275-80. PubMed ID: 2414478
[TBL] [Abstract][Full Text] [Related]
8. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer].
Kageyama T; Oyabu H; Ohshiba S
Gan No Rinsho; 1986 Sep; 32(11):1416-20. PubMed ID: 3773269
[TBL] [Abstract][Full Text] [Related]
9. Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients.
Watanabe M; Tsuru S; Aiso S; Hibi T; Yoshida T; Asakura H; Zinnaka Y; Tsuchiya M
J Clin Lab Immunol; 1984 May; 14(1):29-34. PubMed ID: 6748044
[TBL] [Abstract][Full Text] [Related]
10. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
Gupta S; Cunningham-Rundles S
J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
Kondo H; Seno N; Matsuo S; Otagaki S; Matsuki T; Hatayama T
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
Takada M
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
[TBL] [Abstract][Full Text] [Related]
13. [Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].
Kikuchi S
Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):283-99. PubMed ID: 6749105
[TBL] [Abstract][Full Text] [Related]
14. In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in connection with its high level in tumor-bearing mice.
Shibata Y; Tamura K; Ishida N
Cancer Res; 1983 Jun; 43(6):2889-96. PubMed ID: 6221795
[TBL] [Abstract][Full Text] [Related]
15. [Studies of the cellular immune response in patients with urinary bladder carcinoma. X. Evaluation of serum IAP and ASP levels].
Nishio S; Ozaki Y; Wada S; Kawakita J; Maekawa M
Hinyokika Kiyo; 1984 Apr; 30(4):449-57. PubMed ID: 6485956
[TBL] [Abstract][Full Text] [Related]
16. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome.
Yamaguchi Y; Hihara J; Hironaka K; Ohshita A; Okita R; Okawaki M; Matsuura K; Nagamine I; Ikeda T; Ohara M; Hamai Y
Oncol Rep; 2006 Apr; 15(4):895-901. PubMed ID: 16525677
[TBL] [Abstract][Full Text] [Related]
17. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Watanabe H; Yokoe T; Hiro J; Ojima E; Tanaka K; Kusunoki M
J Surg Oncol; 2008 Apr; 97(5):404-8. PubMed ID: 18181167
[TBL] [Abstract][Full Text] [Related]
18. [Activity of non-specific T-suppressors regulating the proliferation of B- and T-lymphocytes in patients with fibroadenomatosis, breast cancer and stomach cancer].
Grinevich IuA; Drannik GN; Nikol'skiĭ IS; Kalinina NA; Litvishchenko EI
Vopr Onkol; 1984; 30(12):23-7. PubMed ID: 6240157
[TBL] [Abstract][Full Text] [Related]
19. [Immunological significance of splenectomy in gastric cancer surgery. Production of immunosuppressive factor in the spleen].
Kanayama H; Oda M; Karino T; Yamane T; Hamazoe R; Osaki Y; Shimizu N; Maeta M; Koga S
Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):952-6. PubMed ID: 6676666
[TBL] [Abstract][Full Text] [Related]
20. [Immunosuppressive factor in the sera of patients with stomach cancer--with special reference to IAP (immunosuppressive acidic protein)].
Shimizu N; Izumi A; Ozaki Y; Kanayama H; Maeda M; Koga S
Gan No Rinsho; 1982; 28(2):125-8. PubMed ID: 7182557
[No Abstract] [Full Text] [Related]
[Next] [New Search]
